1. Home
  2. Detail

@yentuixinh2: #túi_xách_đẹp #túixách #hottrend

Bảo Yến Túi 👜
Bảo Yến Túi 👜
Open In TikTok:
Region: VN
Friday 18 September 2026 06:53:14 GMT
111
0
0
2

Music

Download

No Watermark .mp4 (3.45MB) No Watermark(HD) .mp4 (3.45MB) Watermark .mp4 (3.63MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @yentuixinh2, please go to the Tikwm homepage.

Other Videos

I love you father 😘❤️ #foryoupage #write4sukoon
I love you father 😘❤️ #foryoupage #write4sukoon


iseng iseng berhadiah tapi hadiah nya gak iseng... #totaldrama #football #vng
iseng iseng berhadiah tapi hadiah nya gak iseng... #totaldrama #football #vng
#🖤🤕✋🏿
#🖤🤕✋🏿
Journavx is a recently FDA-approved non-opioid oral pain medication for adults with moderate-to-severe acute pain. It works by selectively blocking the NaV1.8 sodium channel in peripheral pain-sensing nerves — reducing pain signals before they reach the central nervous system. It’s the first new oral pain drug class in over 20 years and was approved for short-term postoperative and injury-related pain. Clinical trials showed significant pain reduction after surgeries like abdominoplasty and bunionectomy, with a safety profile that included itching, muscle spasms, CPK elevation, and rash. Why it matters: • Non-opioid option → lower abuse and addiction risks • Works peripherally, not centrally • Helps reduce opioid exposure after surgery #Journavx #Suzetrigine #AcutePain #PainManagement #opiodepidemic #PainMedicine #PostOpPain #SurgeryRecovery #MedicalEducation #PhysicianContent #medicine #healthcare #EvidenceBasedMedicine #HealthTech #HealthEducation #MedicalEducation #meded #ClinicalInnovation #vertebroplasty #kyphoplasty #vertexpharmaceuticals #Stryker #Medtronic #JohnsonandJohnson #DePuySynthes
Journavx is a recently FDA-approved non-opioid oral pain medication for adults with moderate-to-severe acute pain. It works by selectively blocking the NaV1.8 sodium channel in peripheral pain-sensing nerves — reducing pain signals before they reach the central nervous system. It’s the first new oral pain drug class in over 20 years and was approved for short-term postoperative and injury-related pain. Clinical trials showed significant pain reduction after surgeries like abdominoplasty and bunionectomy, with a safety profile that included itching, muscle spasms, CPK elevation, and rash. Why it matters: • Non-opioid option → lower abuse and addiction risks • Works peripherally, not centrally • Helps reduce opioid exposure after surgery #Journavx #Suzetrigine #AcutePain #PainManagement #opiodepidemic #PainMedicine #PostOpPain #SurgeryRecovery #MedicalEducation #PhysicianContent #medicine #healthcare #EvidenceBasedMedicine #HealthTech #HealthEducation #MedicalEducation #meded #ClinicalInnovation #vertebroplasty #kyphoplasty #vertexpharmaceuticals #Stryker #Medtronic #JohnsonandJohnson #DePuySynthes
Openart is the method rn!!! #openart #fyp #software #ai #sidehustle
Openart is the method rn!!! #openart #fyp #software #ai #sidehustle

About

Legal